Search research articles
Contact Us
Filters
Showing results (1-10 of 119) with videos related to
Page
of 12
Sort By:
Breast Cancer Research : BCR
|
April 5, 2011
Stratifying triple-negative breast cancer: which definition(s) to use?
Barbara Adamo, Carey K Anders
Clinical Breast Cancer
|
July 15, 2009
Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer
Carey K Anders, Lisa A Carey
Oncology (Williston Park, N.Y.)
|
November 29, 2013
New targets for triple-negative breast cancer
Christina I Herold, Carey K Anders
Current Breast Cancer Reports
|
July 4, 2012
Treatment of Breast Cancer Brain Metastases
Rachel A Freedman, Carey K Anders
Annals of Translational Medicine
|
June 19, 2018
Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies
Evelyn M Brosnan, Carey K Anders
The American Journal of Pathology
|
August 21, 2017
Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures
William B Coleman, Carey K Anders
Oncology (Williston Park, N.Y.)
|
October 19, 2018
Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are Going
Anureet C Copeland, Carey K Anders
International Journal of Breast Cancer
|
March 31, 2012
Triple-negative breast cancer: an update on neoadjuvant clinical trials
Keith D Amos, Barbara Adamo, Carey K Anders
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Breast cancer in adolescents and young adults: a review with a focus on biology
Jill R Tichy, Elgene Lim, Carey K Anders
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics
Carey K Anders, Vandana Abramson, Tira Tan, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 119) with videos related to
Sort By:
Page
of 12
Breast Cancer Research : BCR
|
April 5, 2011
Stratifying triple-negative breast cancer: which definition(s) to use?
Barbara Adamo, Carey K Anders
Clinical Breast Cancer
|
July 15, 2009
Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer
Carey K Anders, Lisa A Carey
Oncology (Williston Park, N.Y.)
|
November 29, 2013
New targets for triple-negative breast cancer
Christina I Herold, Carey K Anders
Current Breast Cancer Reports
|
July 4, 2012
Treatment of Breast Cancer Brain Metastases
Rachel A Freedman, Carey K Anders
Annals of Translational Medicine
|
June 19, 2018
Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies
Evelyn M Brosnan, Carey K Anders
The American Journal of Pathology
|
August 21, 2017
Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures
William B Coleman, Carey K Anders
Oncology (Williston Park, N.Y.)
|
October 19, 2018
Dual HER2-Targeting in the Adjuvant Setting: Where We Have Been and Where We Are Going
Anureet C Copeland, Carey K Anders
International Journal of Breast Cancer
|
March 31, 2012
Triple-negative breast cancer: an update on neoadjuvant clinical trials
Keith D Amos, Barbara Adamo, Carey K Anders
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Breast cancer in adolescents and young adults: a review with a focus on biology
Jill R Tichy, Elgene Lim, Carey K Anders
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 2, 2016
The Evolution of Triple-Negative Breast Cancer: From Biology to Novel Therapeutics
Carey K Anders, Vandana Abramson, Tira Tan, et al.
Page
of 12